Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally

Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally

Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally · Investor's Business Daily

Biotech stock Longboard launched to a record high Tuesday after the company announced promising test results for a seizure treatment.